What's The BUZZ?

Market News, Products, Services, and Trends

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

Inline_file-8061-1722372580.jpg


Amneal Pharmaceuticals

Amneal Pharmaceuticals News & Announcements

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe